Blog
FDA commits to develop guidance for clinical trial stakeholders
The US Food and Drug Administration (FDA) recently made two announcements indicating a commitment to addressing questions about the clinical trial process for clinical trial stakeholders, The National Law Review reports. FDA announced two actions in late...
Pearl IRB’s Robert Seevers will deliver lecture to Purdue University drug discovery class
Robert Seevers, Senior Advisor and Adjunct Board Member at Pearl IRB, has been invited to deliver a lecture at Purdue University this Friday, February 16. Seevers will speak to an MS-level drug discovery class that aims to teach students how to...
Implementation of Common Rule changes delayed: FAQs on the new Common Rule
New Common Rule - FAQ Changes to the Common Rule, the principal rule regulating human subjects research, go into effect on July 19, 2018. A number of Pearl IRB policies and procedures will be updated as a result of the changes to the rule. Please note that...
Annual “Day of Caring” event with Concord Neighborhood Center in Indianapolis
On Friday, January 19, 2018, we celebrated our annual Pearl IRB "Day of Caring" event. Each year, we partner with a local organization in need to give back to the community. This year, Pearl partnered with Concord Neighborhood Center in downtown...
Former FDA regulatory scientist joins Pearl IRB
Pearl IRB is proud to announce the hiring of Robert Seevers, PhD as Senior Advisor and Adjunct Board Member. Seevers brings over 40 years of experience in pharmaceutical research and development for both large and small molecules. His expertise includes CMC...